Rxivist logo

The need for high-affinity, SARS-CoV-2-specific monoclonal antibodies (mAbs) is critical in the face of the global COVID-19 pandemic, as such reagents can have important diagnostic, research, and therapeutic applications. Of greatest interest is the ~300 amino acid receptor binding domain (RBD) within the S1 subunit of the spike protein because of its key interaction with the human angiotensin converting enzyme 2 (hACE2) receptor present on many cell types, especially lung epithelial cells. We report here the development and functional characterization of 29 nanomolar-affinity mouse SARS-CoV-2 mAbs created by an accelerated immunization and hybridoma screening process. Differing functions, including binding of diverse protein epitopes, viral neutralization, impact on RBD-hACE2 binding, and immunohistochemical staining of infected lung tissue, were correlated with variable gene usage and sequence. ### Competing Interest Statement The authors have declared no competing interest.

Download data

  • Downloaded 449 times
  • Download rankings, all-time:
    • Site-wide: 74,409
    • In immunology: 2,242
  • Year to date:
    • Site-wide: 40,713
  • Since beginning of last month:
    • Site-wide: 74,432

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide